178 related articles for article (PubMed ID: 23583370)
1. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.
Chang HL; Chen CY; Hsu YF; Kuo WS; Ou G; Chiu PT; Huang YH; Hsu MJ
Biochim Biophys Acta; 2013 Aug; 1830(8):4053-64. PubMed ID: 23583370
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade.
Huang SW; Chyuan IT; Shiue C; Yu MC; Hsu YF; Hsu MJ
J Cell Mol Med; 2020 Jan; 24(2):1822-1836. PubMed ID: 31821701
[TBL] [Abstract][Full Text] [Related]
4. The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.
Huang YH; Huang SW; Hsu YF; Ou G; Huang WJ; Hsu MJ
Sci Rep; 2015 Oct; 5():15900. PubMed ID: 26510776
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade.
Yen CS; Chen JC; Chang YF; Hsu YF; Chiu PT; Shiue C; Chuang YF; Ou G; Hsu MJ
Sci Rep; 2016 Apr; 6():25082. PubMed ID: 27122225
[TBL] [Abstract][Full Text] [Related]
6. p53 in trichostatin A induced C6 glioma cell death.
Hsu YF; Sheu JR; Hsiao G; Lin CH; Chang TH; Chiu PT; Wang CY; Hsu MJ
Biochim Biophys Acta; 2011 May; 1810(5):504-13. PubMed ID: 21376104
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
[TBL] [Abstract][Full Text] [Related]
8. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c.
Ghavami S; Mutawe MM; Hauff K; Stelmack GL; Schaafsma D; Sharma P; McNeill KD; Hynes TS; Kung SK; Unruh H; Klonisch T; Hatch GM; Los M; Halayko AJ
Biochim Biophys Acta; 2010 Apr; 1803(4):452-67. PubMed ID: 20045437
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin.
Hwang KE; Na KS; Park DS; Choi KH; Kim BR; Shim H; Jeong ET; Kim HR
Invest New Drugs; 2011 Oct; 29(5):945-52. PubMed ID: 20464445
[TBL] [Abstract][Full Text] [Related]
10. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
11. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
13. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
15. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
16. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
17. Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.
Otsuki T; Sakaguchi H; Hatayama T; Fujii T; Tsujioka T; Sugihara T; Takata A; Hyodoh F; Eto M
Oncol Rep; 2004 May; 11(5):1053-8. PubMed ID: 15069546
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
Koyuturk M; Ersoz M; Altiok N
Cancer Lett; 2007 Jun; 250(2):220-8. PubMed ID: 17125918
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
Conde M; Michen S; Wiedemuth R; Klink B; Schröck E; Schackert G; Temme A
BMC Cancer; 2017 Dec; 17(1):889. PubMed ID: 29282022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]